Status:

COMPLETED

Effects of Exenatide on Postprandial Hyperlipidemia and Inflammation

Lead Sponsor:

Carl T. Hayden VA Medical Center

Conditions:

Type 2 Diabetes Mellitus

Impaired Glucose Tolerance

Eligibility:

All Genders

35-70 years

Phase:

PHASE4

Brief Summary

The primary goal of this study is to determine the acute effects of exenatide on postprandial hypertriglyceridemia. Secondary goals are to determine whether there are additional improvements in postpr...

Eligibility Criteria

Inclusion

  • Recently diagnosed type 2 diabetes (within 3 years) on diet or IGT
  • Fasting triglyceride levels \>140 and \< 400 mg/dl and values varying less than 35% between two screening measurements
  • Normal liver function tests and white blood cell count

Exclusion

  • Type 2 Diabetes for \> 3 years or HbA1c ≥ 7.5
  • Known or suspected Type 1 Diabetes
  • Any diabetes medications in the past 3 weeks, TZD in the prior 3 months or prior regular use of insulin
  • Creatinine \> 2.0 mg/dl or other evidence of active kidney disease
  • Hepatic enzyme elevation \> 2x normal
  • Known Nonalcoholic Fatty Liver Disease
  • Malabsorption of fat or other nutrients, severe lactose intolerance or other significant gastrointestinal or pancreatic problems
  • Recent history of nausea or vomiting
  • Acute bacterial or viral illness or evidence of other active infection in the past 4 weeks
  • A prior cardiovascular event, stable or unstable angina or other major illness in the past 6 months
  • Current regular use of anti-inflammatory medications or antioxidants, including over the counter medications and high dose salicylates (\>1 g/day)
  • Any lipid lowering therapy in the prior 3 weeks other than a statin medication. Subjects receiving a statin medication must be on a stable dose for at least 2 months prior to participation.

Key Trial Info

Start Date :

August 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 1 2008

Estimated Enrollment :

39 Patients enrolled

Trial Details

Trial ID

NCT00974272

Start Date

August 1 2006

End Date

November 1 2008

Last Update

September 10 2009

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Phoenix VA Medical Center

Phoenix, Arizona, United States, 85012